You can buy or sell Heat Biologics and other stocks, options, ETFs, and crypto commission-free!
Heat Biologics, Inc. Common Stock, also called Heat Biologics, is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. Read More The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Durham, NC.
Durham, North Carolina
52 Week High
52 Week Low
Expected Nov 14, Pre-Market